A Phase 1 Study of KHK 4323 in Healthy Volunteers and Subjects With Atopic Dermatitis

Condition:   Atopic Dermatitis Interventions:   Drug: KHK4323 IV/S;   Drug: KHK4323 SC/S;   Drug: KHK4323 IV/M;   Drug: Placebo IV/S;   Drug: Placebo IV/M;   Drug: Placebo SC/S Sponsor:   Kyowa Hakko Kirin Co., Ltd Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials